About this trial
The primary objective of this study was to examine whether three nudging strategies influence beverage consumption behavior among Chinese university students. These interventions included health warning messages, hedonic labeling, and a combination of health warning and hedonic labeling. A between-subjects experimental design with a single factor was employed to assess the effects of these strategies on students' choices between sugar-sweetened and sugar-free beverages, thereby evaluating their effectiveness in promoting healthier beverage selections.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
college students
willing to participate
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
choice architecture
BehavioralShowing the various harms that can come from long-term excessive consumption of sugary beverages on the platform.
choice architecture
BehavioralThe platform shows the hedonic information about sugar-free beverages.
choice architecture
BehavioralThe platform shows both hedonic information about sugar-free beverages and information on the various harms of long-term excessive sugary beverage consumption.
Treatment groups
Trial outcomes
Primary outcomes
The proportion (or likelihood) of selecting sugar-free beverages
The probability of choosing a sugar-free beverage (binary outcome: sugar-sweetened = 0, sugar-free = 1) across five menu-selection tasks.
Secondary outcomes
Participants' Perceived Intrusiveness of Nudges
A 5-point Likert scale (1 = strongly disagree, 5 = strongly agree) was employed. Higher scores indicate greater perceived intrusiveness.
Participants' Support for Nudges
A 5-point Likert scale (1 = strongly disagree, 5 = strongly agree) was employed. Higher scores indicate greater support for the nudging strategy
Participants' Perceived effectiveness of Nudges
A 5-point Likert scale (1 = strongly disagree, 5 = strongly agree) was employed. Higher scores indicate greater perceived effectiveness.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.